01 1Zhejiang Huahai Pharmaceutical
01 1CANAGLIFLOZIN
01 1China
01 1Active
01 1Complete
GDUFA
DMF Review : Complete
Rev. Date : 2017-01-08
Pay. Date : 2016-09-27
DMF Number : 30879
Submission : 2016-09-20
Status : Active
Type : II
20
Zhejiang Huahai Pharmaceutical Co Ltd, based in China, is a pharmaceutical company that stands out with its certifications from FDA and EDQM.
One of their notable products is CANAGLIFLOZIN, with a corresponding US DMF Number 30879.
Remarkably, this DMF maintains an Active status since its submission on September 20, 2016, highlighting commitment to regulatory compliance.
Their GDUFA DMF Review was successfully complete, with a review date of January 08, 2017, and payment made on September 27, 2016, indicating their dedication to facilitating drug approvals, Categorized as Type II
